Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

29.95
Delayed Data
As of Mar 24
 +1.55 / +5.46%
Today’s Change
13.92
Today|||52-Week Range
30.37
+18.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues44.2M51.6M56.8M62.4M
 
 
 
 
 
Cost of Goods Sold1.6M2.1M2.8M3.1M
 
 
 
 
 
Depreciation And Amortization429.0K688.0K600.0K671.0K
 
 
 
 
 
 
Operating ExpensesGross Income42.2M48.9M53.4M58.6M
 
 
 
 
 
General Expenses35.7M37.2M33.5M42.3M
 
 
 
 
 
Research And Development10.6M11.1M7.9M13.3M
 
 
 
 
 
Total Operating Expenses37.8M40.0M37.0M46.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.4M11.6M19.8M16.3M
 
 
 
 
 
Extraordinary Credit101.0K123.0K125.0K100.0K
 
 
 
 
 
Extraordinary Charge-382.0K0.000.00-289.0K
 
 
 
Interest Expense On Debt1.5M1.5M1.2M951.0K
 
 
 
 
 
Other Expenses-4.0K2.0K-1.0K-13.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income5.0M10.7M19.1M15.6M
 
 
 
 
 
Income Taxes-200.0K-405.0K-42.7M-1.2M
 
 
 
 
 
Net Income4.8M10.3M61.8M14.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.2M49.4M49.5M49.7M
 
 
 
 
 
Shares To Calculate EPS Diluted51.2M51.7M52.0M52.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.08$0.18$1.18$0.26
 
 
 
 
 
EPS Diluted$0.08$0.18$1.18$0.28